
Glymark-M1
Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.

Glimepiride 2 mg + Metformin 500 mg (SR)
Glymark-M2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for patients requiring stronger glycemic control. It supports insulin secretion and improves peripheral insulin sensitivity.
One tablet once or twice daily with meals, or as directed by a physician.
General information only. Follow your physician's prescription.
Store below 30°C in a dry place. Protect from light and moisture.
The information provided is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the guidance of a qualified physician regarding any medical condition or medication.

Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.

Vildagliptin 50 mg + Metformin HCl 500 mg
A DPP-4 inhibitor plus Metformin combination for comprehensive Type 2 Diabetes management.

Bilastine 20 mg + Montelukast 10 mg
A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.